Displayed is a scatterplot of primary tumor latency ordered by mouse birth date with older birth dates on the left and younger birth dates on the right. Below the graph is a general breakdown of which year the mouse was born, which facility they were housed, and which researcher was the primary caregiver. Tumor latency did not correlate with birth order, mouse facility, or researcher. Wnt1-Early and Wnt1-Late tumors were randomized into one of two treatment groups: untreated or erlotinib (an EGFR inhibitor). Drug treatment was initiated when primary tumors reached a width between ~5-10 mm. The percent change in tumor volume after 14 days of treatment was compared to the untreated control group to measure drug response. Table S1 Click here to Download Table S2 Click here to Download Table S3 Click here to Download Table S4 Click here to Download Table S5 Disease Models & Mechanisms: doi:10.1242/dmm.037192: Supplementary information 
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